1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Protein Drugs Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 Antibody Drugs
1.2.3 Peptide Hormones
1.2.4 Blood Products
1.2.5 Enzymes
1.3 Market by Application
1.3.1 Global Protein Drugs Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Protein Drugs Market Perspective (2017-2028)
2.2 Protein Drugs Growth Trends by Region
2.2.1 Protein Drugs Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Protein Drugs Historic Market Size by Region (2017-2022)
2.2.3 Protein Drugs Forecasted Market Size by Region (2023-2028)
2.3 Protein Drugs Market Dynamics
2.3.1 Protein Drugs Industry Trends
2.3.2 Protein Drugs Market Drivers
2.3.3 Protein Drugs Market Challenges
2.3.4 Protein Drugs Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Protein Drugs Players by Revenue
3.1.1 Global Top Protein Drugs Players by Revenue (2017-2022)
3.1.2 Global Protein Drugs Revenue Market Share by Players (2017-2022)
3.2 Global Protein Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Protein Drugs Revenue
3.4 Global Protein Drugs Market Concentration Ratio
3.4.1 Global Protein Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Protein Drugs Revenue in 2021
3.5 Protein Drugs Key Players Head office and Area Served
3.6 Key Players Protein Drugs Product Solution and Service
3.7 Date of Enter into Protein Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Protein Drugs Breakdown Data by Type
4.1 Global Protein Drugs Historic Market Size by Type (2017-2022)
4.2 Global Protein Drugs Forecasted Market Size by Type (2023-2028)
5 Protein Drugs Breakdown Data by Application
5.1 Global Protein Drugs Historic Market Size by Application (2017-2022)
5.2 Global Protein Drugs Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Protein Drugs Market Size (2017-2028)
6.2 North America Protein Drugs Market Size by Country (2017-2022)
6.3 North America Protein Drugs Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Protein Drugs Market Size (2017-2028)
7.2 Europe Protein Drugs Market Size by Country (2017-2022)
7.3 Europe Protein Drugs Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Protein Drugs Market Size (2017-2028)
8.2 Asia-Pacific Protein Drugs Market Size by Country (2017-2022)
8.3 Asia-Pacific Protein Drugs Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Protein Drugs Market Size (2017-2028)
9.2 Latin America Protein Drugs Market Size by Country (2017-2022)
9.3 Latin America Protein Drugs Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Protein Drugs Market Size (2017-2028)
10.2 Middle East & Africa Protein Drugs Market Size by Country (2017-2022)
10.3 Middle East & Africa Protein Drugs Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Eli Lilly
11.1.1 Eli Lilly Company Detail
11.1.2 Eli Lilly Business Overview
11.1.3 Eli Lilly Protein Drugs Introduction
11.1.4 Eli Lilly Revenue in Protein Drugs Business (2017-2022)
11.1.5 Eli Lilly Recent Development
11.2 Abbott Laboratories
11.2.1 Abbott Laboratories Company Detail
11.2.2 Abbott Laboratories Business Overview
11.2.3 Abbott Laboratories Protein Drugs Introduction
11.2.4 Abbott Laboratories Revenue in Protein Drugs Business (2017-2022)
11.2.5 Abbott Laboratories Recent Development
11.3 UCB Group
11.3.1 UCB Group Company Detail
11.3.2 UCB Group Business Overview
11.3.3 UCB Group Protein Drugs Introduction
11.3.4 UCB Group Revenue in Protein Drugs Business (2017-2022)
11.3.5 UCB Group Recent Development
11.4 Schering-Plough Corporation
11.4.1 Schering-Plough Corporation Company Detail
11.4.2 Schering-Plough Corporation Business Overview
11.4.3 Schering-Plough Corporation Protein Drugs Introduction
11.4.4 Schering-Plough Corporation Revenue in Protein Drugs Business (2017-2022)
11.4.5 Schering-Plough Corporation Recent Development
11.5 Genentech
11.5.1 Genentech Company Detail
11.5.2 Genentech Business Overview
11.5.3 Genentech Protein Drugs Introduction
11.5.4 Genentech Revenue in Protein Drugs Business (2017-2022)
11.5.5 Genentech Recent Development
11.6 Johnson?Johnson
11.6.1 Johnson?Johnson Company Detail
11.6.2 Johnson?Johnson Business Overview
11.6.3 Johnson?Johnson Protein Drugs Introduction
11.6.4 Johnson?Johnson Revenue in Protein Drugs Business (2017-2022)
11.6.5 Johnson?Johnson Recent Development
11.7 Bristol-Myers Squibb
11.7.1 Bristol-Myers Squibb Company Detail
11.7.2 Bristol-Myers Squibb Business Overview
11.7.3 Bristol-Myers Squibb Protein Drugs Introduction
11.7.4 Bristol-Myers Squibb Revenue in Protein Drugs Business (2017-2022)
11.7.5 Bristol-Myers Squibb Recent Development
11.8 Novo Nordisk
11.8.1 Novo Nordisk Company Detail
11.8.2 Novo Nordisk Business Overview
11.8.3 Novo Nordisk Protein Drugs Introduction
11.8.4 Novo Nordisk Revenue in Protein Drugs Business (2017-2022)
11.8.5 Novo Nordisk Recent Development
11.9 Biogen Idec
11.9.1 Biogen Idec Company Detail
11.9.2 Biogen Idec Business Overview
11.9.3 Biogen Idec Protein Drugs Introduction
11.9.4 Biogen Idec Revenue in Protein Drugs Business (2017-2022)
11.9.5 Biogen Idec Recent Development
11.10 Dendreon Corporation
11.10.1 Dendreon Corporation Company Detail
11.10.2 Dendreon Corporation Business Overview
11.10.3 Dendreon Corporation Protein Drugs Introduction
11.10.4 Dendreon Corporation Revenue in Protein Drugs Business (2017-2022)
11.10.5 Dendreon Corporation Recent Development
11.11 Amgen Inc.
11.11.1 Amgen Inc. Company Detail
11.11.2 Amgen Inc. Business Overview
11.11.3 Amgen Inc. Protein Drugs Introduction
11.11.4 Amgen Inc. Revenue in Protein Drugs Business (2017-2022)
11.11.5 Amgen Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
